With 67% ownership of the shares, Creo Medical Group PLC (LON:CREO) is heavily dominated by institutional owners

In This Article:

Key Insights

  • Institutions' substantial holdings in Creo Medical Group implies that they have significant influence over the company's share price

  • A total of 9 investors have a majority stake in the company with 51% ownership

  • Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business

Every investor in Creo Medical Group PLC (LON:CREO) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 67% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

Let's delve deeper into each type of owner of Creo Medical Group, beginning with the chart below.

View our latest analysis for Creo Medical Group

ownership-breakdown
AIM:CREO Ownership Breakdown January 28th 2024

What Does The Institutional Ownership Tell Us About Creo Medical Group?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Creo Medical Group. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Creo Medical Group, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
AIM:CREO Earnings and Revenue Growth January 28th 2024

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. We note that hedge funds don't have a meaningful investment in Creo Medical Group. Canaccord Genuity Asset Management Limited is currently the company's largest shareholder with 12% of shares outstanding. M&G Investment Management Limited is the second largest shareholder owning 9.7% of common stock, and Development Bank of Wales Plc holds about 5.7% of the company stock.

On further inspection, we found that more than half the company's shares are owned by the top 9 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.